March 08, 2026 01:04 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Iranian drone strike near Dubai Intl. Airport's terminal forces emergency flight suspensions | 26-year-old Hindu man killed after Holi altercation with Muslim neighbour in Delhi’s Uttam Nagar; four arrested | Zohran Mamdani defends wife amid scrutiny over her 'support' for Palestinian cause | Explosions rock club in Kolkata’s Paikpara, locals claim bombs were stored inside | Iran conflict: White House says US could achieve ‘Operation Epic Fury’ objectives in 4–6 weeks | Sensex, Nifty tumble as global tensions and Dow selloff rattle Indian markets | Two IAF pilots killed as Su-30MKI fighter jet crashes in Assam | 'Who is the US to permit?': Congress slams Modi govt over Trump administration’s waiver on India’s Russian oil purchase | US makes surprise move: India gets 30-day waiver to buy Russian oil amid global supply crisis | India edge England by 7 runs in thriller to reach T20 World Cup 2026 final
Adar Poonawalla
Image Credit: Adar Poonawalla Twitter

Serum Insititute chief Adar Poonwalla to get 'Y-category' security cover

| @indiablooms | Apr 29, 2021, at 02:26 am

New Delhi/IBNS: Pune-based Serum Institute of India's chief Adar Poonawalla will be provided with 'Y-category' security across the country, media reports said.

The order was issued by the Union Home Ministry following an assessment of the threats received by Poonawalla.

"Y category" security means he will be covered by 11 security personnel, out of which one or two of them will be commandos and the rest policemen.

Serum Institute came under heavy criticism after it announced the pricing of its Covishield vaccine to the states for the 18 to 45 age group at Rs. 400 a shot, which is way above the Rs.150 price offered to the Centre.

The revised pricing has provoked anger among many and opposition leaders as well as social media users have demanded "One vaccine one price".

On Wednesday, the Serum Institute announced a 25 per cent reduction in price for the states and will now offer Covishiled at Rs. 300 instead of Rs. 400.

"As a philanthropic gesture on behalf of @SerumInstIndia, I hereby reduce the price to the states from Rs.400 to Rs.300 per dose, effective immediately; this will save thousands of crores of state funds going forward. This will enable more vaccinations and save countless lives," Poonawalla tweeted.
 

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.